EBOS Group Limited Share Price and Company Fundamentals
Last traded: Yesterday at 4:00 AM
EBOS Group Limited engages in the marketing, wholesale, and distribution of healthcare, medical, pharmaceutical, and animal care products in Australia, Southeast Asia, and New Zealand. It operates through Healthcare and Animal Care segments. The company provides healthcare logistics; medication management solutions; pharmacy management software; loyalty, generics, compliance, business intelligence, and store software services; and health communications, programs, and consultancy services. It also offers community based health care services and programs; vitamins, minerals and supplements, herbal and fruit teas, and natural toothpastes, as well as functional foods, including molasses and manuka honey; Pharmacy Choice, a five step integrated retail program for independent pharmacies; and healthSAVE, a community pharmacy banner that helps members drive their retail businesses. Further, it offers healthcare distribution, warehousing, clinical trial management, and product registration services; clinical trial logistics; aesthetic healthcare devices, medical-grade cosmeceuticals, and injectables; and surgical devices and medical consumables. Additionally, the company provides pet nutrition, treats, clean-up, and grooming products and accessories; and wholesales veterinary products. The company was formerly known as Early Bros Dental & Surgical Supplies Ltd. and changed its name to EBOS Group Limited in 1986. EBOS Group Limited was incorporated in 1922 and is headquartered in Docklands, Australia.
Key Metrics
PE ratio
18.55
PB ratio
1.44
Dividend yield
5.12%
Beta
0.18
Market cap
$4.72B
Enterprise value
$7.35B
Company profile
| Industry / Sector | Medical Distribution / Healthcare |
|---|---|
| Full time employees | 5800 |
| Website | https://www.ebosgroup.com |
| Mailing address | 737 Bourke Street Level 7 Docklands VIC 3008 Australia |
| Phone / Fax | 61 3 9918 5555 / 61 3 9918 5599 |
Dividends
Dividend yield
5.12%
Dividend amount
$1.19
Payout ratio
94.93%
5Y Avg. yield
-%
EBOS Group Limited paid $1.19 dividend and the ex-dividend date was 05 Mar 2026.The dividend payout ratio is 94.93%. The dividend payout ratio is defined as the amout of dividend paid divided by the earnings of the company.EBO dividend payout ratio is more than 90% making it difficult for the company to maintain the dividends and increase it year by year.
Company Executives
As of Mar 2026, following are the company executives and directors listed on EBOS Group Limited.
| Name | Title | Age | Total Pay |
|---|---|---|---|
| Mr. Adam Luke Hall B.Com., BCOMM, L.L.B., LLB (HONS), M.B.A. | Chief Executive Officer | 50 | |
| Mr. Alistair Gray | Chief Financial Officer | ||
| Mr. Leonard Hansen | Chief Accountant & Chief Risk Officer | ||
| Mr. Mithran Naiker | Chief Information Officer | ||
| Ms. Janelle Cain | General Counsel | ||
| Mr. Martin Krauskopf | Chief Strategy & Corporate Development Officer | ||
| Ms. Jacinta McCarthy | Executive General Manager of Human Resources | ||
| Mr. Simon Bunde | Executive General Manager of Strategic Operations, ESG & Innovation | ||
| Mr. Grant Viney | Chief Executive Officer of EBOS Animal Care | ||
| Ms. Kristine James | CEO of Medical Technology |
Profitability and management effectiveness
Profit margin
1.76%
Operating margin
2.76%
Return on assets
3.56%
Return on equity
8.97%
Profitability ratios are a class of financial metrics that are used to assess a business's ability to generate earnings relative to its revenue, operating costs, balance sheet assets, and shareholders' equity over time, using data from a specific point in time.
The return on equity signifies how well the management is running the company in terms of capital management. The ideal return on equity is greater than 10%. The return on equity is calculated as net income divided by total share holders equity.
Valuation and Trading Info
The market capitalization of EBOS Group Limited is 4.72B and its enterprise value is 7.35B. The enterprise value to revenue ratio of EBO is 0.33. The enterprise value to EBITDA ratio of EBO is 14.78.
The EBO's stocks Beta value is 0.18 making it 82% less volatile compared to NZX market index. Technology stocks and small caps tend to have higher betas than the market benchmark. This indicates that adding the stock to a portfolio will increase the portfolio’s risk, but also increase its expected return. On the other hand utility stocks often have low betas because they tend to move more slowly than market averages.
EBOS Group Limited (NZX:EBO) Frequently Asked Questions
1. What is EBOS Group Limited's Stock Symbol?
EBOS Group Limited trades on NZX under the ticker symbol "EBO".
2. What is EBOS Group Limited's stock price today?
One share of EBO stock can currently be purchased for approximately $23.
3. How can I contact EBOS Group Limited?
EBOS Group Limited's mailing address is 737 Bourke Street Level 7 Docklands VIC 3008 Australia. The company can be reached via phone at 61 3 9918 5555.
4. What is EBOS Group Limited's official website?
The official website of EBOS Group Limited is https://www.ebosgroup.com.